Translation and validation of the Standard Chinese version of the EORTC QLQ-C30
Translation and validation of the Standard Chinese version of the EORTC QLQ-C30
复制标题
DOI：
10.1023/a:1008981520920
复制
发表时间：
2000-03-01
影响因子：
3.5
通讯作者：
Kanda, K
中科院分区：
文献类型：
--
作者：
Zhao, H;Kanda, K
大多数生活质量(QOL)问卷都是在英语或西欧国家开发和使用的。本研究的目的是提供欧洲癌症研究与治疗组织生活质量核心问卷(EORTC QLQ-C30 2.0版)的中文标准版，并对其心理测量学特性进行评估。翻译过程包括独立翻译、回译、妇科癌症患者的试点测试，以及原始开发者的审查和批准。主要研究对象包括妊娠滋养细胞疾病患者(n=68)、卵巢癌患者(n=105)和其他类型的妇科癌症患者(n=18)。简体中文版的平均完成时间为8.1+/-2.9分钟。除第1、5、20、25项外，其余条目与分量表的相关系数均超过条目收敛效度标准(r>；0.40)，且除第1、20、25项外，其余条目与自身分量表的相关显著高于与其他分量表的相关程度。各分量表之间的相关系数均达到显著水平(r=0.40~0.70)。九个分量表中有七个达到了信度的最低标准(Cronbach‘s Alpha>；0.70)。综上所述，EORTC QLQ-C30中文版是评价中国妇科癌症患者生活质量的有效工具。
The majority of quality of life (QOL) questionnaires have been developed and used in English-speaking or Western European countries. The aims of this study were to provide the Standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30 version 2.0), and evaluate its psychometric properties. The translation process included independent translation, back translation, a pilot test with gynecological cancer patients, and a review and approval by the original developers. Participants in the major study included gestational trophoblastic disease patients (n = 68), ovarian cancer patients (n = 105), and other types of gynecological cancer patients (n = 18). The average completion time of the Standard Chinese version was 8.1 +/- 2.9 min. All item-subscale correlation coefficients exceeded the criterion of item-convergent validity (r > 0.40) except item 1, 5, 20, and 25, and all items correlated significantly higher with their own subscale than with other subscales except item 1, 20, and 25. The correlation coefficients among all subscales were significant but modest (r = 0.40-0.70). Seven out of nine subscales met the minimal standards of reliability (Cronbach's alpha > 0.70). In conclusion, the Standard Chinese version of the EORTC QLQ-C30 is a valid instrument overall in assessing the QOL of Chinese gynecological cancer patients.